Kopran Limited (NSE:KOPRAN)
India · Delayed Price · Currency is INR 274.39
-5.03 (-1.80%)
Sep 24, 2026, 1:50 PM IST
Kopran Market Cap
Kopran has a market cap or net worth of 13.49 billion as of September 23, 2026. Its market cap has increased by 56.30% in one year.
Market Cap
13.49B
Enterprise Value
15.01B
Revenue
7.00B
Ranking
n/a
PE Ratio
53.98
Stock Price
274.39
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 13.49B, an increase of 2,257.72%. That is a compound annual growth rate of 13.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 13.49B | 86.32% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 286.80B |
| Pfizer | 182.94B |
| Marksans Pharma | 153.21B |
| CORONA Remedies | 133.42B |
| Sanofi Consumer Healthcare India | 91.96B |
| Senores Pharmaceuticals | 63.55B |
| SMS Pharmaceuticals | 43.69B |
| Sai Parenteral's | 22.57B |